Schedule 13G ownership disclosure

KINIKSA PHARMACEUTICALS INTL

Class A Ordinary Shares, nominal value $0.000273235 per share · CUSIP: G52694109

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Fairmount Funds Management LLC

    Shares: 0.00 · Class: 0.0%

  • Fairmount Healthcare Fund II L.P.

    Shares: 0.00 · Class: 0.0%

  • Peter Harwin

    Shares: 0.00 · Class: 0%

  • Tomas Kiselak

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-014002
Form type
SCHEDULE 13G/A
Filer
Fairmount Funds Management LLC
CIK
CIK 1802528
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub